Paul Remi Afolabi

Publications

18 publications

Page 1 of 2

Markers of adipose tissue fibrogenesis associate with clinically significant liver fibrosis and are unchanged by synbiotic treatment in patients with NAFLD

Josh Bilson, Carolina J. Oquendo, James Read, Eleonora Scorletti, Paul R. Afolabi, Jenny Lord, Laure B. Bindels, Giovanni Targher, Sumeet Mahajan, Diana Baralle, Philip C. Calder, Christopher D. Byrne & Jaswinder K. Sethi, 2023, Metabolism, 151

DOI: 10.1016/j.metabol.2023.155759

Type: article

Utilising pancreatic exocrine insufficiency in the detection of resectable pancreatic ductal adenocarcinoma

Declan McDonnell, Paul Afolabi, Sam Wilding, Gareth Griffiths, Jonathan Swann, Chris Byrne & Zaed Z.R. Hamady, 2023, Cancers, 15(24)

DOI: 10.3390/cancers15245756

Type: article

Body Mass Index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: unravelling the “obesity paradox” phenomenon

Michael Jennings, Maria Burova, Laura G. Hamilton , Elsie Hunter, Clare Mordena, Ryan Beecham , Darshni Pandya, Helen Moyses, Kordo Saeed, Paul Afolabi, Philip Calder, Ahilanandan Dushianthan, Thomas Wilkinson, Anna Freeman, Michael Celinski, Saul Faust, Gareth J Thomas & Christopher Kipps, 2022, Clinical Nutrition ESPEN, 51, 377 - 384

DOI: 10.1016/j.clnesp.2022.07.016

Type: article

DEPEND study protocol: early detection of patients with pancreatic cancer - a pilot study to evaluate the utility of faecal elastase-1 and 13C-mixed triglyceride breath test as screening tools in high-risk individuals

Paul Remi Afolabi, Declan McDonnell, Christopher D Byrne, Sam Wilding, Victoria Goss, Jocelyn Walters & Zaed Z Hamady, 2022, BMJ Open, 12(2)

DOI: 10.1136/bmjopen-2021-057271

Type: article

Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD

Josh Bilson, Eleonora Scorletti, Laure B. Bindels , Paul Afolabi, Giovanni Targher, Philip Calder, Jaswinder K. Sethi & Christopher Byrne, 2021, Nutrition & Diabetes, 11(1)

DOI: 10.1038/s41387-021-00170-3

Type: article

European guideline on indications, performance and clinical impact of ¹³C-breath tests in adult and pediatric patients

Jutta Keller, Heinz F. Hammer, Paul R. Afolabi, Marc Benninga, Osvaldo Borrelli, Enrique Dominguez-Munoz, Dan Dumitrascu, Oliver Goetze, Stephan L. Haas, Bruno Hauser, Daniel Pohl, Silvia Salvatore, Marc Sonyi, Nikhil Thapar, Kristin Verbeke & Mark R. Fox, 2021, United European Gastroenterology Journal, 9(5), 598-625

DOI: 10.1002/ueg2.12099

Type: review

Factors independently associated with cardiorespiratory fitness in patients with non-alcoholic fatty liver disease

Paul Afolabi, Eleonora Scorletti, Philip Calder & Christopher Byrne, 2020, Liver International, 40(12), 2998-3007

DOI: 10.1111/liv.14618

Type: article

Non-alcoholic fatty liver disease and childhood obesity

M. Shaunak , Christopher Byrne, N. Davis, Paul Afolabi, Saul Faust & Justin Davies, 2020, Archives of Disease in Childhood, 106(1), 3-8

DOI: 10.1136/archdischild-2019-318063

Type: review

The evaluation of the repeatability of the 13C-ketoisocaproate breath test for assessing hepatic mitochondrial function

Paul Afolabi, Eleonora Scorletti, Philip Calder & Christopher Byrne, 2019, Isotopes in Environmental and Health Studies, 55(2), 150-160